Another Benefit of Gout Treatment: CV Risk Reduction

Growing evidence suggests that a guideline-directed, treat-to-target strategy in patients with gout not only controls the disease but also reduces cardiovascular risks.

Related Keywords

Boston ,Massachusetts ,United States ,New York ,Michael Garshick ,Michael Pillinger ,York University Grossman School Of Medicine ,Rheumatology Program ,Annual Cardiometabolic Risk ,Inflammatory Conditions ,New York University Grossman School ,New York City ,Potential Benefits ,Daniel Solomon ,Cardio Rheumatology Program ,Medscape Medical News ,